InspireMD Inc. (NSPR) Enterprise Value to EBITDA Ratio
Serving as the primary valuation tool, this InspireMD, Inc. (NSPR) price chart demonstrates an EV/EBITDA of 0.00, while global sales leave the company dependent on supply chain stability and exchange rates. The business relies on exclusive stroke-protection technologies, maintaining an advantage in the EU and awaiting approval in the US. Zero employee churn is ensured by the engineers' dedication to the coronary stents they develop.
Comprehensive metric breakdowns and analytics for inspiremd.com (NSPR)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
NSPR - Net Financial Result|Projected Future Earnings InspireMD, Inc.|NSPR - Price to Earnings Ratio|Forward P/E Multiple InspireMD, Inc.|NSPR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InspireMD Inc.|NSPR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months InspireMD|NSPR - Earnings per share for the trailing year|Quarterly EPS earnings growth inspiremd.com|NSPR - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year InspireMD, Inc.
Analysis of all company metrics:InspireMD Corp NSPR
This metric aggregates the market value and net debt of InspireMD, Inc. (NSPR), comparing them against operating profit before depreciation and amortization to determine the asset's real price. By analyzing the EV/EBITDA chart, a conservative investor can assess whether the premium pricing of InspireMD, Inc. (NSPR) unique stents justifies the current debt load and overall business capitalization over the long term.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Enterprise Value to Operating Income Before Depreciation BBLG (Bone Biologics Corp.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|Total Company Value to Operating Income Before Depreciation Ratio Biolase Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|FNA (Paragon 28 Inc.) - Company Value to Operating Income Before Depreciation Ratio|INVO Bio - EV/EBITDA Multiple
